• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚氧乙烯-聚氧丙烯嵌段共聚物凝胶互穿交联壳聚糖网络的 5-FU 持续释放。

Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network.

机构信息

Department of Chemical and Material Engineering, National Yunlin University of Science and Technology, Dou-Liu, Yunlin, Taiwan.

出版信息

Int J Pharm. 2009 Dec 1;382(1-2):39-44. doi: 10.1016/j.ijpharm.2009.07.035. Epub 2009 Aug 8.

DOI:10.1016/j.ijpharm.2009.07.035
PMID:19666095
Abstract

This study investigates in vitro the drug delivery characteristics of new thermo-sensitive gels, P-CS/GA gels, in which a chitosan (CS) network is crosslinked with various concentrations of glutaraldehyde (GA) that interpenetrates Poloxamer (P) gels. The results indicate that the swelling ratios of all P-CS/GA gels are markedly superior to those of non-swelling P and P-CS gels. For example, P-CS/GA (0.1 wt.%) gels have swelling ratios of 13.2+/-1.0, which are maintained for approximately 18 h in water at 37 degrees C. In vitro releases of 5-FU from P-CS/GA (0.1 wt.%) gels had significantly lower initial burst release (P<0.01) and lasted much longer than those from gels without a CS network. For example, the duration of release of 5-FU was in a significantly sustained manner for up to 52 h, which was about 10 times or longer than the period of delivery using P or P-CS gels. The release of drugs from gels with an interpenetrating CS network could be modeled by Fickian diffusion; the characteristic constant 'k' of drug-gel systems decreased as increasing GA concentrations in the P-CS/GA gels, and increasing the viscosities of the P, P-CS and P-CS/GA solutions.

摘要

本研究考察了新的温敏凝胶 P-CS/GA 的体外药物传递特性,其中壳聚糖 (CS) 网络与不同浓度的戊二醛 (GA) 交联,GA 互穿聚氧乙烯 (P) 凝胶。结果表明,所有 P-CS/GA 凝胶的溶胀率明显优于非溶胀 P 和 P-CS 凝胶。例如,P-CS/GA(0.1wt%)凝胶的溶胀率为 13.2+/-1.0,在 37°C 水中约 18 小时保持不变。5-FU 从 P-CS/GA(0.1wt%)凝胶中的体外释放具有明显较低的初始突释(P<0.01),并且持续时间比没有 CS 网络的凝胶长得多。例如,5-FU 的释放持续时间显著延长至 52 小时,这大约是使用 P 或 P-CS 凝胶的递送时间的 10 倍或更长时间。具有互穿 CS 网络的凝胶中药物的释放可以通过菲克扩散模型来模拟;药物-凝胶系统的特征常数'k'随着 P-CS/GA 凝胶中 GA 浓度的增加而降低,并且随着 P、P-CS 和 P-CS/GA 溶液的粘度增加而降低。

相似文献

1
Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network.聚氧乙烯-聚氧丙烯嵌段共聚物凝胶互穿交联壳聚糖网络的 5-FU 持续释放。
Int J Pharm. 2009 Dec 1;382(1-2):39-44. doi: 10.1016/j.ijpharm.2009.07.035. Epub 2009 Aug 8.
2
Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman.用于炔诺酮肟控释的戊二醛交联壳聚糖微球
Carbohydr Res. 2007 Nov 5;342(15):2244-52. doi: 10.1016/j.carres.2007.06.009. Epub 2007 Jun 12.
3
Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil.聚(L-谷氨酸)/壳聚糖微胶囊的层层组装用于高负载和 5-氟尿嘧啶的持续释放。
Eur J Pharm Biopharm. 2011 Aug;78(3):336-45. doi: 10.1016/j.ejpb.2010.12.031. Epub 2010 Dec 30.
4
A fibrin encapsulated liposomes-in-chitosan matrix (FLCM) for delivering water-soluble drugs. Influences of the surface properties of liposomes and the crosslinked fibrin network.一种用于递送水溶性药物的纤维蛋白包裹的壳聚糖基质脂质体(FLCM)。脂质体表面性质和交联纤维蛋白网络的影响。
Int J Pharm. 2006 Mar 27;311(1-2):122-9. doi: 10.1016/j.ijpharm.2005.12.038. Epub 2006 Jan 30.
5
Chitosan inserts for periodontitis: influence of drug loading, plasticizer and crosslinking on in vitro metronidazole release.用于牙周炎的壳聚糖植入物:药物负载量、增塑剂和交联对甲硝唑体外释放的影响。
Acta Pharm. 2007 Dec;57(4):469-77. doi: 10.2478/v10007-007-0037-1.
6
Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.两种半乳甘露聚糖和硬葡聚糖作为药物递送载体:制备与释放研究
Eur J Pharm Biopharm. 2007 May;66(2):200-9. doi: 10.1016/j.ejpb.2006.10.024. Epub 2006 Dec 6.
7
Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.负载5-氟尿嘧啶(5-FU)的N-琥珀酰壳聚糖(Suc-Chi)纳米颗粒用于癌症化疗:制备、表征——体外药物释放及抗肿瘤活性
J Pharm Pharmacol. 2006 Sep;58(9):1177-81. doi: 10.1211/jpp.58.9.0003.
8
Evaluation of semi-interpenetrating polymer networks composed of chitosan and poloxamer for wound dressing application.用于伤口敷料应用的壳聚糖和泊洛沙姆组成的半互穿聚合物网络的评估。
Int J Pharm. 2007 Aug 16;341(1-2):35-43. doi: 10.1016/j.ijpharm.2007.03.042. Epub 2007 Apr 1.
9
Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles.载5-氟尿嘧啶壳聚糖/聚乙二醇微粒的控释研究
Drug Deliv. 2009 Jul;16(5):274-9. doi: 10.1080/10717540902987625.
10
FABRICATION AND IN VITRO EVALUATION OF 5-FLOROURACIL LOADED CHONDROITIN SULFATE-SODIUM ALGINATE MICROSPHERES FOR COLON SPECIFIC DELIVERY.用于结肠特定递送的载5-氟尿嘧啶硫酸软骨素-海藻酸钠微球的制备及体外评价
Acta Pol Pharm. 2016 Mar-Apr;73(2):495-507.

引用本文的文献

1
Chitosan/Pluronic F127 Thermosensitive Hydrogel as an Injectable Dexamethasone Delivery Carrier.壳聚糖/泊洛沙姆F127热敏水凝胶作为可注射地塞米松递送载体
Gels. 2022 Jan 7;8(1):44. doi: 10.3390/gels8010044.
2
Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer.采用中空微针给予肿瘤周围注射氟尿嘧啶水凝胶治疗胃癌。
Drug Deliv. 2018 Nov;25(1):872-879. doi: 10.1080/10717544.2018.1455760.
3
Cross-Linked Hydrogel for Pharmaceutical Applications: A Review.用于制药应用的交联水凝胶:综述
Adv Pharm Bull. 2017 Dec;7(4):515-530. doi: 10.15171/apb.2017.064. Epub 2017 Dec 31.